UBS Group’s PhaseRx, Inc. PZRX Stock Holding History

UBS Group’s Portfolio PZRX Stock Details PZRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,844	Closed	-$1K	–	8531
2017 Q4	$1K	Buy	2,844 +942	+50%	+$695	﹤0.01%	7791
2017 Q3	$2K	Buy	+1,902	New	+$1.42K	﹤0.01%	7532
2017 Q1	–	Sell	-2,813	Closed	-$4K	–	8283
2016 Q4	$4K	Buy	2,813 +2,633	+1,463%	+$4.3K	﹤0.01%	7368
2016 Q3	$0	Buy	+180	New	+$587	﹤0.01%	8172

Other funds holding PZRX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group's PZRX Position: Q1 2018 in Review

UBS Group sold out of PhaseRx, Inc. (PZRX) in Q1 2018, closing a stake of 2,844 shares — an estimated $1K sold.

UBS Group first reported a position in PZRX in Q3 2016 and held it in 4 quarters. The position peaked at $4K in Q4 2016. 1 fund tracked by Wall St. Rank holds PZRX as of Q1 2018.

UBS Group reported no remaining PhaseRx, Inc. position as of Q1 2018 after selling out during the quarter.
UBS Group sold 2,844 PhaseRx, Inc. shares in Q1 2018, an estimated $1K.
UBS Group first reported a position in PhaseRx, Inc. in Q3 2016 and held it in 4 quarters.
UBS Group's PhaseRx, Inc. position peaked at $4K in Q4 2016.
1 fund tracked by Wall St. Rank held PhaseRx, Inc. as of Q1 2018.

Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.